ArticleScientific reports2023

Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study.

Zengjun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.